Cargando…

R&D Incentives for Neglected Diseases

Neglected diseases are typically characterized as those for which adequate drug treatment is lacking, and the potential return on effort in research and development (R&D), to produce new therapies, is too small for companies to invest significant resources in the field. In recent years various i...

Descripción completa

Detalles Bibliográficos
Autor principal: Dimitri, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526606/
https://www.ncbi.nlm.nih.gov/pubmed/23284648
http://dx.doi.org/10.1371/journal.pone.0050835